COMMUNIQUÉS West-GlobeNewswire

New Study Reveals 40% of Workplace-Insured Americans Delay Care Due to Cost, Adversely Impacting Workplace Culture and Productivity
19/03/2024
COLUMBIA, Mo., March 19, 2024 (GLOBE NEWSWIRE) -- Paytient , the leading provider of healthcare affordability solutions, released today a study commissioned from independent research group Nonfiction on workplace- [...]
CHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB)
19/03/2024
PRESS RELEASE CHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB) LONDON – 19 March 2024 -- CHARM Therapeutics (“CHARM”, “The Company”), a 3D deep-learning research company discovering and [...]
Gynesonics Announces Key Executive Appointments to Further Accelerate and Expand Adoption of the Sonata Treatment
19/03/2024
REDWOOD CITY, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- Gynesonics ® , Inc. a privately-held women’s healthcare medical device company focused on the development of minimally invasive solutions for symptomatic uterine [...]
Merit Medical Launches the Micro ACE™ Advanced Micro-Access System
19/03/2024
Micro ACE combines a unique balance of stiffness and resiliency to achieve successful micro-access in challenging cases SOUTH JORDAN, Utah, March 19, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), [...]
Ibogaine By David Dardashti Begins Design on Algorithm for Quantum Electrodynamics
19/03/2024
Ibogaine By David Dardashti Develops Algorithm for Quantum Electrodynamics to Optimize Treatment Times MIAMI, March 19, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti is proud to announce the development of a [...]
Medigene AG to participate in the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
19/03/2024
Planegg/Martinsried, March 19, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid [...]
JenaValve’s Trilogy THV System Highlighted at CRT 2024
19/03/2024
IRVINE, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced highlights from the Cardiovascular [...]
Clover Health Launches New Clinical Program in Partnership with Quartet Health to Address Serious Mental Illness
19/03/2024
Partnership aims to improve outcomes through increased support to underserved and at-risk patient populations through Clover’s home-based care model FRANKLIN, Tenn., March 19, 2024 (GLOBE NEWSWIRE) -- Today, Clover [...]
LiveCare Inc. (OTCMKTS: LVCE) Experiences Unprecedented Growth and Technological Advancements Post-Revamp
19/03/2024
Venice, FL, USA, March 19, 2024 (GLOBE NEWSWIRE) -- LiveCare Inc. (OTCMKTS: LVCE), a pioneering force in the Telehealth sector, announces remarkable strides in patient acquisition and recurring monthly revenue growth, [...]
Lowell Farms to Announce Fourth Quarter and Fiscal Year 2023 Financial and Operational Results
19/03/2024
California cannabis leader to hold earnings call with leadership on March 28, 2024 SALINAS, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- Lowell Farms Inc. (CSE:LOWL; OTCQX:LOWLF), a California-born cannabis company with [...]
T2 Biosystems to Host Investor Call on March 20, 2024 to Unveil its T2Lyme Launch Plans and Provide Additional Business Updates
19/03/2024
LEXINGTON, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that [...]
Health-ISAC Publishes 2023 Annual Report
19/03/2024
Report Outlines Accomplishments Towards Global Health Sector Resilience ORMOND BEACH, Fla., March 19, 2024 (GLOBE NEWSWIRE) -- Health-ISAC (Health Information Sharing and Analysis Center), a non-profit, member-driven [...]
Turning Point of Tampa Elevates Recovery Support with Comprehensive Partial Hospitalization Programs
19/03/2024
TAMPA, FL, March 19, 2024 (GLOBE NEWSWIRE) -- Turning Point of Tampa, a revered leader in providing comprehensive treatment solutions for Substance Use Disorder and Eating Disorders, is proud to announce the significant [...]
Scilex Holding Company Announces Repayment in Full of the Remaining Balance of Convertible Debentures and Early Payment of the Senior Secured Promissory Note, Paving the Way for Future Growth and Innovation
19/03/2024
PALO ALTO, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain [...]
iCAD Releases Enhanced ProFound Detection Workstation Features to Streamline Mammogram Interpretation for Radiologists
19/03/2024
Newly released capabilities -- limiting the number of marks on a 3D view, color-coding lesion marks, and color-coding the ProFound Scorecard -- enhance radiologists' interpretability and efficiency NASHUA, N.H., March [...]
SELLAS Life Sciences to Host Corporate Update Call on March 26, 2024, at 8:15 am ET
19/03/2024
- Update on the Phase 3 REGAL Clinical Trial of GPS in Acute Myeloid Leukemia (AML) - - Update on the Phase 2a Clinical Trial of SLS009 in relapsed/refractory AML, including topline data - NEW YORK, March 19, 2024 ( [...]
U.S. Oral Surgery Management Enters Maryland, Adds Five New Partner Practices in Five States
19/03/2024
IRVING, Texas, March 19, 2024 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management (USOSM) is finishing out Q1 2024 strong with the announcement of five new partner practices, including one in Maryland, USOSM’s first [...]
Autonomix Appoints Jennifer Cook as Chief Business Officer
19/03/2024
Proven executive with 28 years of success building winning B2C & B2B businesses, brands, and teams for premier consumer, healthcare, and medical technology brands THE WOODLANDS, TX, March 19, 2024 (GLOBE NEWSWIRE [...]
Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement
19/03/2024
SAN DIEGO, March 19, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of [...]

Pages